share_log

智通港股股东权益披露|9月12日

China Wisdom Hong Kong Stock Shareholder Equity Disclosure | September 12

Zhitong Finance ·  Sep 11 20:05

Disclosure of Hong Kong Stock Shareholders' Rights | September 12

According to data from the Zhitong Finance App, Shisi Pharmaceutical Group (02005), Kangzhe Pharmaceutical (00867), Liankang Biotechnology Group (00690), and Weisheng Holdings (03393) made the latest shareholders' rights disclosure on September 12, 2024.

Stock nameName of institutionnatureShareholding before the changeShareholding after the changeShareholding ratio
Shisi Pharmaceutical Group (02005)China Pharmaceutical Company LimitedYoshikura0.844 billion shares0.846 billion shares28.50% (latest)
28.41% (previous)
Kangzhe Pharmaceutical (00867)Treasure Sea LimitedYoshikura1.163 billion shares1.164 billion shares47.70% (latest)
47.68% (previous)
Liankang Biotechnology Group (00690)Zhao ZhigangYoshikura94.735 million shares93.175 million shares1.51% (latest)
1.54% (previous)
Liankang Biotechnology Group (00690)Leung Kwok LungYoshikura1.68 billion shares1.677 billion shares27.21% (latest)
27.26% (previous)
Weisheng Holdings (03393)JiweiYoshikura0.536 billion shares0.536 billion shares53.85% (latest)
53.81% (previous)
Kangzhe Pharmaceutical (00867)Lin GangYoshikura1.163 billion shares1.164 billion shares47.70% (latest)
47.68% (previous)
Shisi Pharmaceutical Group (02005)Qu JiguangYoshikura1.129 billion shares1.131 billion shares38.11% (latest)
38.02% (previous)
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment